MDL 101731

(redirected from MDL 101,731)

MDL 101731

A drug of the ribonucleotide diphosphate reductase inhibitor family that is a potent antitumour agent against cultured thyroid cancer cells, induceing apoptosis in tumours with increased Fas expression.